Factors affecting the clearance and biodistribution of polymeric nanoparticles.

Factors affecting the clearance and biodistribution of polymeric nanoparticles.
复制标题

DOI:
10.1021/mp800051m
复制
发表时间:
2008-07
影响因子:
4.9
通讯作者:
Farokhzad OC
Farokhzad OC
中科院分区:
医学2区
文献类型:
--
作者:
Alexis F;Pridgen E;Molnar LK;Farokhzad OC

文献摘要

参考文献

被引文献

相似文献

纳米颗粒(NP)药物递送系统(5 - 250 nm)具有改善当前疾病治疗的潜力,因为它们能够克服多种生物屏障并在最佳剂量范围内释放治疗负荷。在全身递送期间循环纳米颗粒的快速清除是这些系统的关键问题,并且使得有必要了解影响颗粒生物分布和血液循环半衰期的因素。本文就影响纳米粒在血液中滞留时间和器官特异性蓄积的因素进行综述。这些因素包括与生物屏障的相互作用和可调纳米颗粒参数,如组成,大小,核心性质,表面修饰(聚乙二醇化和表面电荷),最后,靶向配体功能化。所有这些因素已显示通过降低非特异性摄取水平、延迟调理作用和增加组织特异性蓄积程度,显著影响循环纳米颗粒的生物分布和血液循环半衰期。
Nanoparticle (NP) drug delivery systems (5−250 nm) have the potential to improve current disease therapies because of their ability to overcome multiple biological barriers and releasing a therapeutic load in the optimal dosage range. Rapid clearance of circulating nanoparticles during systemic delivery is a critical issue for these systems and has made it necessary to understand the factors affecting particle biodistribution and blood circulation half-life. In this review, we discuss the factors which can influence nanoparticle blood residence time and organ specific accumulation. These factors include interactions with biological barriers and tunable nanoparticle parameters, such as composition, size, core properties, surface modifications (pegylation and surface charge), and finally, targeting ligand functionalization. All these factors have been shown to substantially affect the biodistribution and blood circulation half-life of circulating nanoparticles by reducing the level of nonspecific uptake, delaying opsonization, and increasing the extent of tissue specific accumulation.
DOI: 10.1200/jco.2005.02.0933
发表时间: 2005-10-20
影响因子: 45.3
作者:
Ascierto, PA;Scala, S;Logan, TF
通讯作者: Logan, TF
DOI: 10.1007/bf00874153
发表时间: 1993-01-01
影响因子: 3.4
作者:
DANHAUSERRIEDL, S;HAUSMANN, E;HANAUSKE, AR
通讯作者: HANAUSKE, AR
DOI: 10.2174/187152807780077273
发表时间: 2007-03-01
期刊: Inflammation & Allergy Drug Targets
影响因子: --
作者:
Chetta, Alfredo;Zanini, Andrea;Olivieri, Dario
通讯作者: Olivieri, Dario
I阶段剂量升级和药代动力学研究对晚期癌症患者的pluronic聚合物结合的阿霉素(SP1049C)。
DOI: 10.1038/sj.bjc.6601856
发表时间: 2004-06-01
影响因子: 8.8
作者:
通讯作者: --
DOI: 10.1016/j.biomaterials.2006.09.047
发表时间: 2007-02-01
期刊: BIOMATERIALS
影响因子: 14
作者:
Cheng, Jianjun;Teply, Benjamin A.;Farokhzad, Omid C.
通讯作者: Farokhzad, Omid C.